The role of sublingual sufentanil nanotabs for pain relief

The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil. This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and cur...

Full description

Saved in:
Bibliographic Details
Published inExpert opinion on drug delivery Vol. 12; no. 5; p. 845
Main Authors Minkowitz, Harold S, Candiotti, Keith
Format Journal Article
LanguageEnglish
Published England 01.05.2015
Subjects
Administration, Sublingual
Analgesia, Patient-Controlled - methods
Analgesics, Opioid - administration & dosage
Analgesics, Opioid - therapeutic use
Animals
Humans
Pain, Postoperative - drug therapy
Sufentanil - administration & dosage
Sufentanil - therapeutic use
Tablets
sufentanil
pain
microtablet
sublingual
Online AccessGet more information

Cover

More Information
Summary:The authors discuss a novel patient controlled analgesia system utilizing a preprogrammed device that delivers a small submucosal tablet of sufentanil. This submucosal sufentanil system is not yet commercially available. A literature review of the current patient controlled analgesia systems and current information of this device are discussed. This novel device has the potential to enhance patient safety as it is preprogrammed and delivers a standard dose of sufentanil, a rapidly acting opioid devoid of active metabolites.
ISSN:1744-7593
DOI:10.1517/17425247.2015.975202